. Author manuscript; available in PMC: 2008 Feb 27.

Published in final edited form as: Am J Drug Alcohol Abuse. 2007;33(3):429–438. doi: 10.1080/00952990701312316

Table 2.

Prevalence of risk-taking behaviors reported among 131 interviewed subjects and associated risk of hospital treatment for GHB

Risk Factor	N (%)	Hospital Treatment Risk OR (95% CI)
Engaging in Sex under the Influence of GHB	84 (64.1)	0.9 (0.4 – 2.1)
Co-Ingestion of Selected Agents with GHB
Ethanol	76 (58.0)	5.2 (1.7 – 16.1)
Ecstasy (Methylene Doxymethamphetamine)	51 (38.9)	1.5 (0.6 – 3.5)
Ketamine	30 (22.9)	2.7 (1.1 – 6.7)
Lifetime Use of GHB > 20 times	55 (42.0)	2.2 (0.9 – 5.3)
Use of GHB while Alone	50 (38.2)	1.8 (0.8 – 4.4)
Driving under the Influence of GHB	38 (29.0)	3.2 (1.3 – 7.8)
Use of a GHB Precursor or Analog	36 (27.5)	1.5 (0.6 – 3.8)
Use of Heroin, Ever	29 (22.1)	0.4 (0.1 – 1.4)
Use of GHB to Treat Withdrawal Symptoms	22 (16.8)	2.9 (1.1 – 7.9)